Tag Archive for: 2023

2023 promises to be yet another year of uncertainty for marketers in general, but what about healthcare marketers?

Did we miss something that will have a major impact on pharma marketing this year? We asked our respondents to write their own questions and answer them.

Regulatory affairs teams within lifescience organizations possess a unique opportunity to drive connected intelligence across the enterprise to support critical operations relating to drug development, safety, and regulatory verticals.

Kite’s Christi Shaw, AbbVie’s Jag Dosanjh, and LexisNexis Risk Solution’s Liz Paulson earn top industry honors.

JP Morgan week is shaping up to approximate pre-pandemic attendance levels as executives return to San Francisco after two years of COVID-19-enforced absences.